Vaccines

A recent study found that a latent cytomegalovirus infection can have a negative effect on mRNA vaccine responsiveness to COVID-19 infection.

A recent study found that understanding and engaging with community-based organizations could help public health officials and care providers disperse accurate information and address disparities surrounding COVID-19 and routine immunizations.

A review found that adverse neonatal and maternal outcomes were not associated with COVID-19 vaccination during pregnancy.

A new study has found that adults who were vaccine hesitant were more likely to show a positive change in opinion when presented with an interactive risk ratio simulation.

Social Security and Medicare spending could double by 2023; FDA panel experts want naloxone to be available over the counter after the drug information is revised; Moderna announced its COVID-19 vaccines will stay free, and the Biden administration might keep tests and treatments free for the uninsured.

A new study found that protection from the Omicron variant waned 6 months after the second dose of a COVID-19 vaccine in older patients.

The Advisory Committee on Immunization Practices released the update to the Recommended Adult Immunization Schedule for all US residents aged 19 years and older, which has been approved by the CDC and medical groups.

Vaccination rates against influenza and pneumococcus were lower in patients receiving organ transplants who lived outside of urban areas and had lower socioeconomic status.

The FDA is relaxing some time-based deferrals for donating blood; new guidance aims to streamline the COVID-19 vaccination process; Congress has been called on to solidify cannabidiol (CBD) regulations.

A new review found that messenger RNA (mRNA) vaccines were able to prevent COVID-19 infection and severe illness in children aged 5 to 11.

A study found that adherence to the CDC recommendation of mRNA monovalent COVID-19 boosters was low in immunocompromised individuals.

A perspective article discussed the possible approaches that scientists can take in developing a new generation of vaccines to fight against several respiratory viruses.

A new study has found that vaccine effectiveness against infection after 4 doses of the COVID-19 vaccine disappeared after 90 days for Omicron variants BA.2, BA.2.12.1, BA.4, and BA.5, although it remained effective against hospitalizations.

Depending on their COVID-19 vaccination status, there were differences in the sources first responders in Kentucky preferred to receive information from, their willingness to believe conspiracy theories, and the perceived risk of the virus.